UNSPSC 51371908: Acetylmethadol hydrochloride

This classification denotes the hydrochloride form of an opioid receptor agonist with the molecular formula C23H31NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L59OC40KWJ, chemically known as 6-(dimethylamino)-4,4-diphenyl-3-heptanol acetate (ester) but more generally known as acetylmethadol, which bears US NIH Compound Identifier 10517. Acetylmethadol comes in forms base and hydrochloride.

UNSPSC 51371908 Acetylmethadol hydrochloride is a Commodity code covering specialized pharmaceutical products, though recent state and local activity under this code does not align with its nominal scope. The source shows no state or local solicitations for acetylmethadol hydrochloride itself. A single recent opportunity tagged to this code—Seminole County, Florida's IFB for Naloxone and Safe Drug Deactivation Systems—represents a clear mismatch; naloxone is an opioid antagonist used for overdose reversal, not a synthetic opioid medication. The code appears dormant for its intended commodity, with state and local procurement activity either minimal or routed through alternative classification schemes.

Seminole County posted IFB 60459723LAS on June 30, 2026, requesting 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023. The procurement calls for quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with all shipping included in the bid. Vendors must submit electronically, provide unit costs per line item, maintain drug-free workplace certification and E-Verify compliance, and carry workers' compensation, commercial general liability, and professional liability insurance. The contract term runs two years with a one-year renewal option and includes a three-month probationary termination window. Potential FEMA funding introduces federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act. The pricing is fixed-fee, and no explicit set-aside designations appear in the notice. This single opportunity under the code offers limited signal regarding sustained state and local purchasing activity for acetylmethadol hydrochloride or closely related synthetic opioid products in the current market.